Increase of Claudin-5, ICAM-1 and eNOS expressions in human brain endothelial cells by ammonium chloride
-
Nurul Farhana Jufri
, Tharshini Salyam
, Farah Wahida Ibrahim
, Dharrshine Yoganathan
, Asmah Hamid
, Mazlyzam Abdul Latif
, Siti Nurdiyana Mohd Saleh
and Nor Atikah Safirah Juhari
Abstract
Objectives
Lysosomal dysfunction could lead to a failure in the degradation process of waste materials, especially for the elimination of aggregated, misfolded and senescence proteins or organelles. Human brain endothelial cells (HBECs) are a part of the blood-brain barrier and any disruption of lysosomal functions could affect the cellular functions of the HBECs. Protein expression studies on the cells could give an insight to associate lysosomal dysfunction on HBECs homeostasis. The aim of this study was to measure the cellular changes via the expression of several proteins such as Claudin-5, which is a tight junction protein; intracellular adhesion molecule 1 (ICAM-1), an inflammatory marker and endothelial nitric oxide synthase (eNOS), which provides nitric oxide (NO) for vasodilation. These components are important in maintaining homeostasis as the imbalance could lead to endothelial impairment linked brain related disorders such as neurodegenerative disease.
Methods
HBECs were treated with 10 mM ammonium chloride, which is a lysosome inhibitor for 1 h. The protein lysates were collected and subjected for ICAM-1 and Claudin-5 measurement by capillary immunoassay instrument, while eNOS by ELISA.
Results
Claudin-5 and ICAM-1 expression significantly increased (p<0.05). The ELISA results showed eNOS increment (p<0.001) compared to control. Lysosome inhibitor could be associated with accumulation of organelles that can stimulates inflammation and initial cellular responses.
Conclusions
Inhibition of lysosome by the inhibitor increases protein expressions related with endothelial function.
Introduction
Lysosomes are cytosolic organelles that play an important function in degradation mechanisms. It has been recognized to degrade unfolded proteins, aggregated proteins, superfluous proteins, damaged organelles, nucleic acids and toxic components [1, 2]. The degradative actions of lysosomes are mediated by its enzymes such as proteases, lipases, nucleases, phosphatases and other hydrolytic enzymes that break down those components for immediate processing [3]. It exerts maximal enzymatic activity at low pH (≤5). These lysosomal functions are part of autophagy process [4]. Autophagy is a crucial process for the conservation of the overall cellular homeostasis and prevent accumulation of those components in the cell [5]. Such functions are critical to provide protection against aging, cancer, neurodegenerative diseases, and infections [6].
Toxic proteins may accumulate in the cell if the degradation mechanisms could not encounter the overburden of protein misfolding or damaged organelles in the cell. Thus, defective or ineffective cellular clearance of long-lived cells and proteins could lead to the deposition of protein aggregates and exhibit increased evidence in the pathologies of neurodegenerative diseases such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis [7, 8]. Among common risk factors associated with these development are aging and oxidative stress, which lead to the etiology of neurodegenerative diseases [9].
Therefore, lysosome dysfunctions could affect cellular processes, since deficits in protein clearance can impair the balance, especially in the brain. The human brain endothelial cells (HBECs) have a pivotal role as part of the blood–brain barrier (BBB). These cells maintain the homeostatic mechanism by controlling the entry and exit of substances from the blood into the brain. Endothelial cells lining the cerebral blood vessels are the main structure that forming BBB. The tight junction (TJ) proteins glues endothelial cells to each other. Alterations or loss of TJ proteins such as claudin, could result in a compromised BBB [10]. Claudin-5 is highly expressed TJ protein in HBECs and its dysfunction has been demonstrated in neurodegenerative disorders, such as Alzheimer’s disease, multiple sclerosis and psychiatric disorders [11].
The intracellular adhesion molecule 1 (ICAM-1) is expressed on endothelial cells especially due to stimulation of proinflammatory cytokines and invokes a range of proinflammatory responses [12]. An increase in ICAM-1 enables the site for leukocyte binding to inflamed tissues during inflammation and could explain the state of cells in certain conditions [13]. Another important function of endothelial cells is property of vasodilation. The vascular tone is controlled by nitric oxide (NO) produced by NO synthase (NOS). The endothelial NOS (eNOS) controls vascular tone in order to change blood pressure and blood flow conditions under homeostasis and has been used as a marker in vascular dysfunctions [14].
Lysosomal activity impairment can contribute to the progression and detrimental effect to neurological conditions such as Alzheimer’s disease [15]. Lysosome dysfunctions could be induced by chemicals such as ammonium chloride. Ammonium chloride is a well known lysosomal function inhibitor. It has the ability increase the pH in lysosomes and inhibit fusion between autophagosomes and lysosomes autophagy process. Lysosome is an important component for degrading organelles and protein degradation and its dysfunction has been associated with neurodegenerative diseases such as Alzheimer. Reduced autophagy function leads to the accumulation of proteins, lysosomal vesicles contain toxic hydrolases, inflammatory cytokines, reduced eNOS, and increased ROS. A clear fundamental link need to be established on how impairment from the cellular level could affect cerebrovascular pathogenesis. Thus, this study intends to investigate whether lysosomal dysfunction could cause endothelial changes in terms of inflammation status (ICAM-1), vasodilation (eNOS) and tight junction protein expression (Claudin-5) that serve as the main molecules in maintaining physiological endothelial function. The in vitro model used in the present study may serve as a preliminary finding on the cellular changes caused by a lysosome inhibitor on HBECs.
Materials and methods
Cell culture
Human Brain Endothelial Cells-5i (HBEC-5i) were grown in T75 flasks supplied with Dulbecco Modified Eagle’s Medium/Ham’s F-12 (Nacalai Tesque, Japan) media. The media supplemented with 1% penicillin and streptomycin (Nacalai Tesque, Japan) and supplemented with 10% fetal bovine serum (HyClone, South America). All cell lines were grown in incubator supplied with 5% CO2 at 37 °C. The confluency used was around 80% and the passage used was between 5 and 8.
Protein lysate preparation
Human brain endothelial cells were treated with a lysosome inhibitor, ammonium chloride (Sigma Aldrich, United Sates) at 10 mM for 1 h [16]. The control group was not exposed to ammonium chloride. Initially, the cells were washed twice with cold phosphate-buffered saline (PBS) and lysed with cold radioimmunoprecipitation assay (RIPA) lysis buffer (VWR Chemicals, USA). The cells were collected by scraping followed by centrifugation at 13,500 rpm, 4 °C for 15 min to isolate the supernatants.
Protein quantification
Protein quantification was performed using a microplate BCA Protein Assay kit (Thermo Scientific, United States). A total 10 μL of the samples were pipetted in triplicate into a 96-well microplate and 200 μL of the working reagent was added into each well. The plate was mixed for 30 s followed by incubation at 37 °C for 30 min and the absorbance was measured at 562 nm. The optical density was plotted against a standard curve established by using bovine serum albumin in the range of 0–2,000 μg/mL.
ICAM-1 and Claudin-5 protein identification by capillary immunoassay
Capillary immunoassay using Jess (ProteinSimple, United States) is an automated Western blotting system for protein separation and immunodetection. It enables protein analysis in shorter duration time compared to traditional Western blot and can increase the throughput by automating the traditional Western blotting procedure (https://www.proteinsimple.com/jess.html).
The capillary immunoassay standard pack reagent (ProteinSimple, United States) comprising of the ladder and 5X fluorescent master mix was prepared. A total of 4 μg of protein samples were added with 400 mM dithiothreitol (DTT) reagent and heated at 95 °C on a heat block for 5 min. The antibodies were diluted at 1:10 involving primary ICAM-1 mouse monoclonal IgG (Santa Cruz Biotechnology, United States), Claudin-5 mouse monoclonal IgG (Santa Cruz Biotechnology, United States) and the m-IgGk HRP conjugated secondary antibody (Santa Cruz Biotechnology, United States). The chemiluminescent agent was prepared fresh by adding luminol-S and peroxide in 1:1 ratio, followed by vortexing. The prepared samples were pipetted into the assay plate with addition of antibody diluent, primary and secondary antibodies, luminol peroxide. The mixture was centrifuged at 1,000×g for 5 min at room temperature and analysis was conducted using a Jess automated capillary-based immunoassay instrument (BioTechne, United States). Compass software (Protein Simple, USA) was used to analyze the peaks and densitometric bands.
Measurement of eNOS concentration by human eNOS ELISA kit
The eNOS concentrations of the control and treatment groups were determined using a commercially produced human eNOS ELISA kit (Elabscience, USA). This kit enables the determination of eNOS concentrations in the range of 62.50–4,000 pg/mL with a sensitivity of 37.50 pg/mL. The eNOS level in protein lysates was plotted in reference to the standard graph plotted using a set of standards prepared as suggested in the kit manual. Briefly, a total of 100 μL protein lysate sample was added into a well on the ELISA microplate. Then, 100 μL biotinylated detection antibody were added to each microplate well and followed by incubation and washing. Next, 90 µL the substrate solution was added to each well. The reaction was terminated by the addition of 50 µL stop solution before the optical density was measured at wavelength of 450 nm using microplate reader (Biorad, USA).
Statistical analysis
Each sample was measured in triplicate and the data were shown as the means±standard error of the mean (SEM). SPSS (IBM, United States) 25.0 was used to analyzed the data. Normality and homogeneity of variance tests were performed to ensure that the data were homogeneous and normally distributed. T-test was performed to analyze the differences between groups and considered statistically significant at p<0.05.
Results
Claudin-5 expression on human brain endothelial cells in control and treated samples
Figure 1 shows that the Claudin-5 protein expression was significantly increased (p<0.05) in cells treated for 1 h with 10 mM ammonium chloride. Control samples (1C) showed a protein expression of 20,313.6±1,637.1 pixels, whereas the treated group (1T) demonstrated a higher protein expression of 66,829.5±3,937.7 pixels. Based on the densitometry analysis, a higher intensity band of phospho-Claudin-5 was observed in the treated samples. Moreover, a higher chemiluminescence signal of phospho-Claudin-5 was detected in the treated samples compared to the control samples.

Claudin-5 protein identification by capillary immunoassay. (A) Densitometry analysis and chemiluminescence signals of the control, (B) densitometry analysis and chemiluminescence signals of samples treated for 1 h with 10 mM ammonium chloride, (C) * indicates significant increase (p<0.05) of Claudin-5 expression in cells treated for 1 h with 10 mM ammonium chloride. Data are expressed in means±SEM. All experiments were conducted in triplicate.
ICAM-1 expression on human brain endothelial cells in control and treated samples
ICAM-1 protein expression was significantly increased (p<0.05) in the cells treated with 10 mM ammonium chloride (Figure 2). Control samples (1C), showed a protein expression of 2,592,090.0±159,696.0 pixels, whereas the treated group demonstrated a higher protein expression of 515,588.7±448,555.0 pixels. Based on the densitometry analysis, a higher intensity band of ICAM-1 was observed for the treated samples compared to the control samples. Moreover, a higher chemiluminescence signal of ICAM-1 was detected in the treated samples compared to the control samples.

ICAM-1 protein identification by capillary immunoassay. (A) Densitometry analysis and chemiluminescence signals of the control, (B) densitometry analysis and chemiluminescence signals of samples treated for 1 h with 10 mM ammonium chloride, (C) * indicates significant increase (p<0.05) of ICAM-1 expression. Data are expressed in means±SEM. All experiments were conducted in triplicate.
Determination of eNOS concentration in human brain endothelial cells
The concentration of eNOS in samples was determined in reference to the standard graph using the optical density (OD) obtained from the cell lysate at a wavelength of 450 nm. The eNOS concentration in the control and treated groups are shown in Figure 3. Based on the results, the eNOS concentration in the treatment group (602.5±119.5 pg/mL) increased significantly (p<0.001) compared to the control group (544±66.5 pg/mL).

Concentration of eNOS in human brain endothelial cells lysate of control and treatment group (triplicate). Treatment group was treated for 1 h with 10 mM ammonium chloride. * indicates significant increase (p<0.001) of eNOS concentration. Data were expressed in means±SEM. All experiments were conducted in triplicate.
Discussion
HBECs are part of the BBB that are crucial in the maintenance of brain permeability. Neurogenerative disorders such as Alzheimer’s disease can cause dysfunctions within the BBB, as degenerated endothelium was observed in the brain vasculature of Alzheimer’s disease patients. This is closely related with the HBEC, as its endothelial dysfunction is increasingly implicated in the development of cardiovascular pathology, neurodegenerative diseases and aging. Recently, lysosomal dysfunction has been highlighted as important in the cellular response to stressor and has been associated to many diseases. The loss of lysosomal autophagy may be one of the mechanisms that elicits functional loss of the HBECs that is contributed by the increase of reactive oxygen species (ROS), inflammation, and loss of tight junction proteins. Thus, this study investigated the cellular changes in HBECs exposed to a lysosome inhibitor through the quantification of claudin-5, ICAM-1 and eNOs that are important molecules in maintain endothelium functions.
In this study, the lysosomotropic agent ammonium chloride, an established lysosomal function inhibitor was used to inhibit the lysosome function in HBECs in order to see their direct effects on these cells through changes in selected protein expressions. Ammonium chloride could penetrate the lysosome, which is an acidic membrane bound organelle and accumulate as protonated forms. This will cause an increase in the intravesicular pH and inhibition of the endosome lysosome system acidification that prevent the normal functioning of the lysosome [17]. In addition, it can prevent the autophagic flux and increased the level of misfolded proteins, that cause elevated stress in the cell [17]. Expression of Claudin-5, ICAM-1 and eNOS were identified in this study and it was found that all parameters in the treated group had significant increases compared to control in a short duration of time.
Claudins are part of membrane proteins built in the TJs of endothelial cells for paracellular pores and barriers. Thus, claudins determine the permeability properties of endothelial cells and has been used as potential markers of BBB integrity [18]. Increased Claudin-5 expression has shown to demonstrate a neuroprotective role in neurodegenerative diseases [19]. HBECs treated with ammonium chloride was initially expected to have reduced Claudin-5 expression due to increased TJ permeability from chemical exposure, as the increase in BBB permeability was due to nitrosative stress, which is a type of oxidative stress [20]. However, previous study on Claudin-5 knockdowns model demonstrated that size-selective opening of the BBB for molecules smaller than 800 Da occurred rather than general breakdown of TJs [21].
Accumulation of aggregated proteins due to exposure to environmental stimuli leads to endothelial stress, this will trigger specific response pathways within cells to encounter the events via clearance of the defective proteins [22]. The endothelial cells will remodel its structure and trigger adaptive changes in endothelial cell signaling, creating a control mechanism to maintain the cellular homeostasis [23]. Another study found that the endocytosis of claudin is essential for the regulation of claudin content in the paracellular barrier [24]. Claudins can be targeted for degradation or for recycling to the plasma membrane. Claudins are endocytosed into endothelial cells in large double membrane vesicles and crossover endocytosed Claudin-5 was found to be increased after inhibition of lysosomal degradation using a lysosome inhibitor by chloroquine [25]. Turnover of Claudin-5 is continuous with the protein having a moderately short in vitro half-life of 90 min [25]. This might suggest that Claudin-5 expression increased depending on the exposure concentration to certain chemicals at certain durations that can determine the extent of damage incurred to endothelial cells. In another study, ammonium chloride has been found to increased claudin level indicating that it is normally rapidly trafficked to lysosomes [26]. Increase of claudin levels could be partly caused by the inhibition of autophagic degradation that is mediated by lysosome [27]. Autophagy activation forms an isolation membrane involved cytoplasmic constituents in a double membrane structure known as autophagosome that will fuse with lysosomes to form an autophagolysosome for the degradation of the molecules or cargo. Lysosome function inhibition could mediate the accumulation of claudin from being degraded.
Lysosome dysfunctions can cause an accumulation of metabolites or autophagosomes that are not degraded within the cells, and this may lead to increased expression marker for inflammation process. The expression of vascular adhesion molecules mediated for the leukocyte transmigration process is minimal or undetectable under physiological conditions and stimulation of inflammation may increase the ICAM-1 expression [28]. In the study, the upregulated ICAM-1 expression was observed after 1 h of treatment compared to the control group. This indicates that brain inflammation has initiated may be due to the accumulation of autophagosomes and non-degradable metabolites in endothelial cells due to lysosome or autophagy dysfunctions. In the early phase of brain inflammation, the neutrophil will interact with endothelium cells by binding to the ICAM-1 and during this process the expression of endothelial cell ICAM-1 increases further [29]. In addition, ICAM-1 can also result in the accumulation of leukocytes and adhesions on endothelium cells that can damage the BBB, allowing inflammatory cells such as granulocytes to infiltrate the brain and release neurotoxic substances that injure neurons [28]. Our finding suggests that inhibition of the lysosome function can induce an early inflammatory response in HBECs through increased ICAM-1 expression.
Endothelial cells play an important role in maintaining the vascular tone by producing endothelial nitric oxide synthase (eNOS) which provides nitric oxide (NO). On the other hand, the bioavailability of NO is impaired in endothelial dysfunction. There are several common regulatory mechanisms involving eNOS activity such as calcium/calmodulin and caveolin, which control activating phosphorylation by AMP-activated protein kinase (AMPK) as well as localization of eNOS [30]. ROS is generated by the accumulation of dysfunctional organelles due to lysosome dysfunctions [31]. A study showed that ROS, such as hydrogen peroxide (H2O2), increases the expression of eNOS by regulating the calcium/calmodulin-dependent protein kinase II (CaMKII) mechanism [32]. CaMKII is a serine/threonine kinase that involves in transduction of intracellular Ca2+ signals. Bradykinin treatment, an agent that induces Ca2+ influx, results in rapid Ca2+ influx as well as transient activation of CaMKII and eNOS in human umbilical vein endothelial cells [33]. Therefore, the results from this study might suggest that increased expression of eNOS might serve as a regulatory mechanism at the early exposure of the chemical. These findings might suggest that impaired lysosome dysfunction form the inhibitor could be associated with accumulated of claudin protein yet to be degraded that can give in activation of inflammation response and the ROS produced could stimulate the increase of eNOS formation.
Conclusions
In conclusion, our study showed that HBECs treated with ammonium chloride exhibit increased expression of Claudin-5, ICAM-1 and eNOS, which we suggest may act as early cellular responses to a lysosome inhibitor.
Funding source: Ministry of Higher Education Malaysia
Award Identifier / Grant number: FRGS/1/2019/SKK06/UKM/03/5.
Funding source: Universiti Kebangsaan Malaysia
Award Identifier / Grant number: GGPM-2017-044
Acknowledgments
We wish to express our appreciation to Miss Heng Kai Yen for her assistance in conducting the experiment.
-
Research funding: This work was financially supported by the Ministry of Higher Education Malaysia (FRGS/1/2019/SKK06/UKM/03/5) and Universiti Kebangsaan Malaysia (GGPM-2017-044).
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: Not applicable.
References
1. Yim, WWY, Mizushima, N. Lysosome biology in autophagy. Cell Discov 2020;6:1–12. https://doi.org/10.1038/s41421-020-0141-7.Search in Google Scholar PubMed PubMed Central
2. Rahman, MA, Rhim, H. Therapeutic implication of autophagy in neurodegenerative diseases. BMB Rep 2017;50:34–5. https://doi.org/10.5483/bmbrep.2017.50.7.069.Search in Google Scholar PubMed PubMed Central
3. Perera, RM, Zoncu, R. The lysosome as a regulatory hub. Annu Rev Cell Dev Biol 2016;32:223–53. https://doi.org/10.1146/annurev-cellbio-111315-125125.Search in Google Scholar PubMed PubMed Central
4. Lawrence, RE, Zoncu, R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol 2019;21:133–42. https://doi.org/10.1038/s41556-018-0244-7.Search in Google Scholar PubMed
5. Uddin, M, Stachowiak, A, Mamun, AA, Tzvetkov, NT, Takeda, S, Atanasov, AG, et al.. Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci 2018;10:1–18. https://doi.org/10.3389/fnagi.2018.00004.Search in Google Scholar PubMed PubMed Central
6. Levine, B, Kroemer, G. Autophagy in the pathogenesis of disease. Cell 2008;132:27–42. https://doi.org/10.1016/j.cell.2007.12.018.Search in Google Scholar PubMed PubMed Central
7. Saha, S, Panigrahi, DP, Patil, S, Bhutia, SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother 2018;104:485–95. https://doi.org/10.1016/j.biopha.2018.05.007.Search in Google Scholar PubMed
8. Koh, JY, Kim, HN, Hwang, JJ, Kim, YH, Park, SE. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc. Mol Brain 2019;12:1–11. https://doi.org/10.1186/s13041-019-0439-2.Search in Google Scholar PubMed PubMed Central
9. Hohn, A, Tramutola, A, Cascella, R. Proteostasis failure in neurodegenerative diseases: focus on oxidative stress. Oxid Med Cell Longev 2020;2020:1–21. https://doi.org/10.1155/2020/5497046.Search in Google Scholar PubMed PubMed Central
10. Abbott, NJ, Patabendige, AA, Dolman, DE, Yusof, SR, Begley, DJ. Structure and function of the blood–brain barrier. Neurobiol Dis 2010;37:13–25. https://doi.org/10.1016/j.nbd.2009.07.030.Search in Google Scholar PubMed
11. Greene, C, Hanley, N, Campbell, M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS 2019;16:1–15. https://doi.org/10.1186/s12987-019-0123-z.Search in Google Scholar PubMed PubMed Central
12. Lawson, C, Wolf, S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009;61:22–32. https://doi.org/10.1016/s1734-1140(09)70004-0.Search in Google Scholar PubMed
13. Wang, CY, Chiang, TH, Chen, CL, Tseng, PC, Chien, SY, Chuang, YJ, et al.. Autophagy facilitates cytokine-induced ICAM-1 expression. Innate Immun 2014;20:200–13. https://doi.org/10.1177/1753425913488227.Search in Google Scholar PubMed
14. Siragusa, M, Fleming, I. The eNOS signalosome and its link to endothelial dysfunction. Arch Eur J Physiol 2016;468:1125–37. https://doi.org/10.1007/s00424-016-1839-0.Search in Google Scholar PubMed
15. Cupino, TL, Zabel, MK. Alzheimer’s silent partner: cerebral amyloid angiopathy. Transl Stroke Res 2014;5:330–7. https://doi.org/10.1007/s12975-013-0309-7.Search in Google Scholar PubMed
16. Yu, C, Huang, X, Xu, Y, Li, H, Su, J, Zhong, J, et al.. Lysosome dysfunction enhances oxidative stress-induced apoptosis through ubiquitinated protein accumulation in Hela cells. Anat Rec 2013;296:31–9. https://doi.org/10.1002/ar.22612.Search in Google Scholar PubMed
17. Misinzo, G, Delputte, PL, Nauwynck, HJ. Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells. J Virol 2007;82:1128–35. https://doi.org/10.1128/jvi.01229-07.Search in Google Scholar
18. Günzel, D, Yu, AS. Claudins and the modulation of tight junction permeability. Physiol Rev 2013;93:525–69. https://doi.org/10.1152/physrev.00019.2012.Search in Google Scholar PubMed PubMed Central
19. Lv, J, Hu, W, Yang, Z, Li, T, Jiang, S, Ma, Zet al.. Focusing on claudin-5: a promising candidate in the regulation of BBB to treat ischemic stroke. Prog Neurobiol 2018;161:79–96. https://doi.org/10.1016/j.pneurobio.2017.12.001.Search in Google Scholar PubMed
20. Skowronska, M, Zielinska, M, Wojcik‐Stanaszek, L, Ruszkiewicz, J, Milatovic, D, Aschner, M, et al.. Ammonia increases paracellular permeability of rat brain endothelial cells by a mechanism encompassing oxidative/nitrosative stress and activation of matrix metalloproteinases. J Neurochem 2012;12:125–34. https://doi.org/10.1111/j.1471-4159.2012.07669.x.Search in Google Scholar PubMed PubMed Central
21. Nitta, T, Hata, M, Gotoh, S, Seo, Y, Sasaki, H, Hashimoto, et al.. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice. J Cell Biol 2003;161:653–60. https://doi.org/10.1083/jcb.200302070.Search in Google Scholar PubMed PubMed Central
22. Ulloa-Aguirre, A, Hanyaloglu, AC, Zarinan, T, Janovick, JA. Protein Homeostasis Diseases. United States: Academic Press; 2020.Search in Google Scholar
23. Chen, HY, Moussa, ID, Davidson, C, Kassab, GS. Impact of main branch stenting on endothelial shear stress: role of side branch diameter, angle and lesion. J R Soc Interface 2012;9:1187–93. https://doi.org/10.1098/rsif.2011.0675.Search in Google Scholar PubMed PubMed Central
24. Liu, J, Jin, X, Liu, KJ, Liu, W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood–brain barrier damage in early ischemic stroke stage. J Neurosci 2012;32:3044–7. https://doi.org/10.1523/jneurosci.6409-11.2012.Search in Google Scholar PubMed PubMed Central
25. Gehne, N, Lamik, A, Lehmann, M, Haseloff, RF, Andjelkovic, AV, Blasig, IE. Cross-over endocytosis of claudins is mediated by interactions via their extracellular loops. PLoS One 2017;12:1–21. https://doi.org/10.1371/journal.pone.0182106.Search in Google Scholar PubMed PubMed Central
26. Lu, R, Johnson, DL, Stewart, L, Waite, K, Elliott, D, Wilson, JM. Rab14 regulation of claudin-2 trafficking modulates epithelial permeability and lumen morphogenesis. Mol Biol Cell 2014;25:1744–54. https://doi.org/10.1091/mbc.e13-12-0724.Search in Google Scholar
27. Zhang, C, Yan, J, Xiao, Y, Shen, Y, Wang, J, Ge, W, et al.. Inhibition of autophagic degradation process contributes to claudin-2 expression increase and epithelial tight junction dysfunction in TNF-α treated cell monolayers. Int J Mol Sci 2017;18:157. https://doi.org/10.3390/ijms18010157.Search in Google Scholar PubMed PubMed Central
28. Cheng, Y, Zhang, Y, Song, H, Feng, J. Intercellular adhesion molecule-1 expression in the hippocampal ca1 region of hyperlipidemic rats with chronic cerebral ischemia. Neural Regen Res 2012;7:1312–7. https://doi.org/10.3969/j.issn.1673-5374.2012.17.005.Search in Google Scholar PubMed PubMed Central
29. Paulus, P, Jennewein, C, Zacharowski, K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011;6:11–21. https://doi.org/10.3109/1354750x.2011.587893.Search in Google Scholar PubMed
30. Daiber, A, Xia, N, Steven, S, Oelze, M, Hanf, A, Kroller-Schon, S, et al.. New therapeutic implications of endothelial nitric oxide synthase (eNOS) function/dysfunction in cardiovascular disease. Int J Mol Sci 2019;20:1–34. https://doi.org/10.3390/ijms20010187.Search in Google Scholar PubMed PubMed Central
31. Jin, S. Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2006;2:80–4. https://doi.org/10.4161/auto.2.2.2460.Search in Google Scholar PubMed
32. Cai, H. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol J 2004;37:121–5. https://doi.org/10.1016/j.yjmcc.2004.04.012.Search in Google Scholar PubMed
33. Murthy, S, Koval, OM, Ramiro, DJM, Kumar, S, Nuno, D, Scott, JA, et al.. Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity. PLoS One 2017;12:1–23. https://doi.org/10.1371/journal.pone.0186311.Search in Google Scholar PubMed PubMed Central
© 2023 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- Review
- A dual role of proton pump inhibition on cancer: a critical review
- Opinion Paper
- The consumption of vegetable oils and their possible participation as a neuroprotector
- Research Articles
- Analysis of inappropriate repeated laboratory testing
- SNP based analysis depicts phenotypic variability in heme oxygenase-1 protein
- The D allele of angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with the lung involvement in COVID-19
- The effect of survivin gene in breast cancer risk and prognosis
- Increase of Claudin-5, ICAM-1 and eNOS expressions in human brain endothelial cells by ammonium chloride
- The effect of different anti-inflammatory treatment strategies on process of atherosclerosis in ankylosing spondylitis patients
- Genetic dissection of the Mastl-Arpp19/Ensa-PP2A-B55δ pathway in mammalian cells
- Investigation into miRNA profile in patient groups with and without ST elevation
- Prognostic value of total thiol and D-dimer in patients hospitalized with COVID-19
- Case Report
- The effect of heterophilic antibody interference in thyroglobulin measurement on different immunoassay devices
Articles in the same Issue
- Frontmatter
- Review
- A dual role of proton pump inhibition on cancer: a critical review
- Opinion Paper
- The consumption of vegetable oils and their possible participation as a neuroprotector
- Research Articles
- Analysis of inappropriate repeated laboratory testing
- SNP based analysis depicts phenotypic variability in heme oxygenase-1 protein
- The D allele of angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with the lung involvement in COVID-19
- The effect of survivin gene in breast cancer risk and prognosis
- Increase of Claudin-5, ICAM-1 and eNOS expressions in human brain endothelial cells by ammonium chloride
- The effect of different anti-inflammatory treatment strategies on process of atherosclerosis in ankylosing spondylitis patients
- Genetic dissection of the Mastl-Arpp19/Ensa-PP2A-B55δ pathway in mammalian cells
- Investigation into miRNA profile in patient groups with and without ST elevation
- Prognostic value of total thiol and D-dimer in patients hospitalized with COVID-19
- Case Report
- The effect of heterophilic antibody interference in thyroglobulin measurement on different immunoassay devices